CT scan not necessary to diagnose cancer in patients with unexplained blood clots
the ONA take:
According to a new study published in the New England Journal of Medicine, researchers have found that a CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained deep vein thromboemboli and pulmonary emboli.
For the study, researchers enrolled 854 patients with unexplained blots in the legs, lungs, or both. Patients were randomly assigned to receive basic cancer screening with or without a CT scan of the abdomen and pelvis.
Basic cancer screening involved laboratory blood tests, a chest x-ray, and if applicable, a breast exam, prostate exam, or pap smear.
Results showed there was no difference in the incidence of new cancers between the two groups. Researchers found that about 4% of each group was diagnosed with cancer within the next year.
The study also demonstrated no difference in the number of cancer-related deaths between the two treatment arms.
The findings are expected to ultimately improve patient care and lower screening costs globally.
CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained deep vein thromboemboli.
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Study Affirms Activity of Ibrutinib in Patients With R/R CLL With 17p Deletion
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Longer Maintenance Therapy Duration May Improve Survival in Myeloma
- HRQoL Better Maintained With Pembrolizumab in Ipilimumab-refractory Melanoma
- Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
- MRD Assessment Improves PFS Prediction in Patients With CLL
- Cancer Patients Have Unrealistic Hopes When Entering Clinical Trials
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|